[Treatment of Kaposi's sarcoma].
To conclude, no completely satisfactory form of therapy is available at the moment. Combinations are always desirable: either radiotherapy and chemotherapy or interferon and monochemotherapy. However, the choice of therapeutic schedules depends both on the availability of the drugs which is obviously quite different in developing countries including Central Africa, and on the extent of Kaposi's Sarcoma. It is therefore always advisable to carry out a pre-therapeutic examination to assess the extent of the Kaposian lesions. This requires endoscopic, digestive and bronchial examinations and also histological biopsies. The examination should also include a search for the many opportunistic infections which could be associated.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000628:therapy*; D008297:Male; D012514:Sarcoma, Kaposi / Q000628:therapy*; D012878:Skin Neoplasms / Q000628:therapy*
D000970:Antineoplastic Agents
Traitement du sarcome de Kaposi.